Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Persistence and Compliance of Antiplatelet and Dyslipidemia Agents on Cardiovascular Outcomes in Real World Patients Undergoing Percutaneous Coronary Intervention

NCT03785509 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03785509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03785509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Persistence and Compliance of Antiplatelet and Dyslipidemia Agents on Cardiovascular Outcomes in Real World Patients Undergoing Percutaneous Coronary Intervention
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
April 6, 2017
Completion date
November 30, 2018
Enrollment
47,291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, compliance, medication, hydroxymethylglutaryl-coa reductase inhibitors, percutaneous coronary intervention, persistence, medication, platelet aggregation inhibitors